c
Edmonton
airing now
101.7 FM
|
88.1HD2
airing now
8.85 c
Edmonton
airing now
101.7 FM
|
88.1HD2

Delay in Johnson & Johnson's clinical trials for its COVID-19 vaccine may signal a delay in getting a vaccine

BY , Oct 14, 2020 2:18 AM - REPORT AN ERROR

A man leaves a COVID-19 testing clinic, Tuesday, October 6, 2020 in Montreal. THE CANADIAN PRESS/Ryan Remiorz

The country's chief public health officer says a delay in Johnson & Johnson's clinical trials for its COVID-19 vaccine may signal a delay in getting a vaccine to the general public.

She says everyone wants to see a vaccine ready as quickly as possible, but health and safety should never be compromised.

Johnson & Johnson paused a clinical trial of its COVID-19 vaccine after finding an unexplained illness, which is normal in large-scale studies.

These Phase 3 clinical trials involving human volunteers are supposed to wrap by November and December.

Latest News

Share on

Sign up for the newsletter
We'll deliver best of entertainment right into your inbox
We love to hear from our listeners, so feel free to send us message
whatsUp icon
Message us on whatsapp